Related by context. All words. (Click for frequent words.) 70 retinal disorders 69 gastrointestinal disorders characterized 68 ophthalmic diseases 67 retinal diseases 66 ocular inflammatory 65 dermatological disorders 65 fibrotic diseases 64 acetonide FA 64 diabetic macular edema DME 64 dermatological diseases 64 macular degeneration diabetic retinopathy 64 inflammatory diseases 63 immuno inflammatory diseases 63 immunological diseases 63 neurodegenerative diseases 63 kidney urologic 63 cardiovascular metabolic 63 glaucoma cataract 62 ophthalmologic disorders 62 rheumatoid arthritis psoriasis 62 small molecule therapeutics 62 diagnostic molecular imaging 62 retinal dystrophies 62 posterior uveitis 62 commercializes innovative biopharmaceuticals 62 immunologic diseases 62 glaucoma macular degeneration 62 autoimmune uveitis 61 psoriasis rheumatoid arthritis 61 neovascular diseases 61 Friedreich Ataxia FRDA 61 ocular disorders 61 NovaBay Aganocide compounds 61 myeloproliferative disorders 61 investigational therapies 61 rheumatoid arthritis Crohn disease 61 Squalamine 61 skeletal muscle weakness 61 infectious diseases autoimmune diseases 61 vascular disorders 61 proliferative diseases 61 eye vitreous hemorrhage 61 fibrotic disorders 61 CNS disorders 61 ophthalmological diseases 61 synthetic retinoid 61 squalamine 61 ocular infections 61 anti infective treatments 61 ophthalmic indications 61 myelofibrosis polycythemia vera 60 therapeutics 60 tiapamil 60 lupus multiple sclerosis 60 targeted radiotherapeutics 60 geographic atrophy 60 autologous cellular therapies 60 diabetic peripheral neuropathy 60 gastrointestinal disorders ATI 60 prokinetic agent 60 diabetic macular edema 60 dermatological 60 Age Related Macular 60 hematologic diseases 60 neurological diseases 60 gastrointestinal disorders 60 neurodegenerative disorders 60 Solazed TM 60 venous stasis ulcers 60 proprietary kinase inhibitor 60 RNAi therapeutic targeting 60 Photodynamic Therapy PDT 60 photodynamic therapy PDT 60 MEK inhibitors 60 cognitive impairment associated 60 BioMarin develops 59 dermatologic conditions 59 inflammatory autoimmune diseases 59 diabetic retinopathy DR 59 neovascular 59 novel therapeutics 59 ocular inflammation 59 Parkinson disease Alzheimer disease 59 AMD diabetic retinopathy 59 NP2 Enkephalin 59 BioSilicon TM 59 inflammatory autoimmune 59 retinal degenerations 59 degenerative disorders 59 coagulation disorders 59 Zemiva TM 59 topical anti infective 59 diarrhea predominant irritable 59 gastroenterology neurology 59 NTDDS 59 herpetic keratitis 59 ischemic diseases 59 acne rosacea 59 inflammatory disorders 59 neuro degenerative diseases 59 systemic fungal infections 59 glaucoma diabetic retinopathy 59 INS# [001] 59 Perceiva 59 TTR amyloidosis 59 siRNA compounds 59 macular degeneration glaucoma 59 ophthalmology dermatology 59 rheumatoid arthritis multiple sclerosis 59 musculoskeletal diseases 59 neuropathic pain 59 acne impetigo 58 Functional Somatic Syndromes 58 topical formulations 58 retinal degenerative diseases 58 photodisinfection 58 pathologic myopia 58 hematological diseases 58 voiding dysfunctions 58 acne vulgaris 58 commercializing therapeutic 58 dermatologic disorders 58 Liprotamase 58 REMOXY R 58 hematological cancers 58 superficial basal cell carcinoma 58 OHR/AVR# 58 OMNARIS HFA 58 Fibromyalgia Syndrome FMS 58 EVIZON TM 58 AzaSite Xtra 58 refractory gout 58 liver cancers hypercholesterolemia 58 choroidal neovascularization 58 EVIZON ™ 58 Nektar proprietary 58 monoclonal antibody therapeutics 58 ESBA# 58 ALN PCS 58 JAK inhibitors 58 GI motility disorders 58 antisense drugs 58 TELINTRA 58 Prolacria 58 inherited retinal 58 glaucoma allergy 58 Genasense evaluating 58 Stargardt Macular Dystrophy SMD 58 hematological disorders 58 SARMs 58 neuropathic pain metabolic diseases 58 anticancer therapies 58 photodynamic 58 psoriasis eczema 58 therapeutic modalities 58 uveitis 58 macular edema secondary 58 diabetic retinopathy hyphema glaucoma 58 Pyridorin 58 RNAi therapeutics 58 IL# PE 58 transdermal delivery 58 diquafosol tetrasodium 58 Accelerating apoptosis may 58 DuraSite 58 sirtuin inhibitor program 58 siRNA therapeutics 58 degenerative neurological diseases 58 novel RNAi therapeutics 58 ATL# [002] 58 neuro inflammatory 58 punctal plug drug 58 Selective Electrochemical Tumor Ablation 57 targeted radiotherapeutic 57 iSONEP TM 57 severe malignant osteopetrosis 57 biologic therapies 57 infectious autoimmune 57 OTCBB AEMD pioneer 57 therapeutic peptides 57 CRVO 57 CINTREDEKIN BESUDOTOX 57 dermatological indications 57 blepharitis 57 refractory angina 57 % uracil topical 57 Levulan PDT 57 metabolic disorders 57 AutoloGel tm System 57 oncology therapeutics 57 trastuzumab DM1 T DM1 57 Medidur TM 57 rheumatologic 57 non alcoholic steatohepatitis 57 REMOXY ® 57 investigational monoclonal antibody 57 Levulan ® PDT 57 Microplasmin 57 ophthalmology oncology 57 immuno inflammatory 57 neuroendocrine cancers 57 PDE4 modulators 57 carcinoid syndrome 57 lipid disorders 57 Xyfid TM 57 onychomycosis 57 Wet AMD 57 dermatologic 57 cataracts glaucoma 57 cardiometabolic disorders 57 superficial basal cell carcinomas 57 epilepsy Parkinson disease 57 chemical entities NCEs 57 Diabetic Macular Edema DME 57 vitreoretinal disorders 57 AA amyloidosis 57 ocular allergies 57 neoplastic diseases 57 hematopoietic malignancies 57 Ception Therapeutics 57 JAK1 57 Sentinel Principle 57 rheumatoid arthritis thrombocytopenia 57 punctal plugs 57 gastrointestinal mucositis 57 treating cancerous tumors 57 p# inhibitor 57 CYT# potent vascular disrupting 57 benign prostatic hypertrophy BPH 57 Behcet uveitis 57 molecular imaging radiopharmaceuticals 57 arterial thrombosis 57 central retinal vein 57 sd rxRNA compounds 57 EVIZON 57 drug ISA# 57 opioid induced constipation 57 respiratory allergy dermatological 56 overactive bladder syndrome 56 oncology indications 56 small molecule 56 commercialize deforolimus 56 Litx 56 autoimmune inflammatory 56 dermatoses 56 injectable collagenase 56 primary axillary hyperhidrosis 56 Intarcia 56 liver cancers TTR 56 HepDirect R 56 hematologic disorders 56 rxRNA 56 renal diseases 56 prostone 56 oncological indications 56 post herpetic neuralgia 56 denufosol tetrasodium 56 ALN TTR# 56 onychomycosis nail fungus 56 Cellegesic 56 neurovascular diseases 56 novel antibody therapeutics 56 HepDirect 56 Entereg R 56 Degeneration AMD 56 IAP inhibitor 56 immunotherapeutics 56 vaccines oncolytic virus 56 Leber Congenital Amaurosis LCA 56 medically refractory 56 constipation OIC 56 glaucoma ischemia 56 pharmacological chaperone 56 related Macular Degeneration 56 Evoltra ® 56 sodium stibogluconate 56 deacetylase inhibitors 56 Stargardt Disease 56 chronic opioid 56 immunodeficiency disorders 56 cardiovascular stents 56 Sudhir Agrawal D.Phil 56 NAGS deficiency 56 immunology oncology 56 Iluvien ® 56 retinal vein occlusion induced 56 hematological malignancies 56 oral transdermal 56 treatmentof 56 wet macular degeneration 56 atypical hemolytic uremic syndrome 56 exon skipping 56 Pervasis 56 delivers fluocinolone acetonide FA 56 novel antiviral therapeutics 56 xerostomia secondary 56 immunotherapeutic approaches 56 induced macular edema 56 psoriasis psoriatic arthritis 56 Oral BDP 56 autoimmune indications 56 sodium thiosulfate STS 56 romazarit 56 autoimmune diseases 56 TRIOLEX HE# APOPTONE HE# 56 pre cancerous actinic 56 thrombotic diseases 56 hypophosphatasia 56 radiation sensitizer 56 cutaneous lupus 56 EyeGate 56 solar keratoses 56 protein misfolding diseases 56 diabetic retinopathy 56 lumbar spinal stenosis LSS 56 alpha interferons 56 NuMimetic TM 56 osteoarthritis rheumatoid arthritis 56 Etubics 56 deCODE Glaucoma TM 56 JAK inhibitor 56 Rescula 56 ILUVIEN ® 56 delay bone metastases 56 acne psoriasis 56 Ph.D. Targacept 56 rxRNA compounds 56 organ transplant rejection 56 samarium Sm 56 PEGylation technology 56 exudative 56 pancreatic NET 56 Central Retinal Vein 56 viral diseases 56 Pseudomonas aeruginosa infections 56 microRNA therapeutics 56 Soliris eculizumab 56 treat cardiac arrhythmias 56 anti angiogenic agents 56 Oracea TM 56 injectable antithrombotics 56 fibrotic disease 56 antibody therapeutics targeting 56 Bob Butchofsky President 56 primary immunodeficiencies 56 Neurodegenerative diseases 56 thetreatment 56 GERD migraine headaches 55 GEM OS2 55 post herpetic neuralgia PHN 55 biodefense vaccines 55 neovascular form 55 oral JAK#/JAK# inhibitor 55 CTLA4 Ig 55 Wafer polifeprosan 55 SinuNase TM 55 benign neoplasms 55 occlusion CRVO 55 actinic keratosis 55 Enkephalin 55 novel immunotherapies 55 treat brain aneurysms 55 Tß4 55 macular edema 55 RNAi therapeutic 55 including thyroiditis RA 55 Nasdaq HALO biopharmaceutical 55 Acute Radiation Syndrome ARS 55 proliferative diabetic retinopathy 55 molecular radiotherapeutics 55 degenerative diseases 55 including acne photodamage 55 diquafosol 55 LHRH antagonists 55 oral leukoplakia 55 ophthalmics 55 Lixivaptan 55 Systemic lupus erythematosus SLE 55 polyneuropathy HIV DSP 55 anemias 55 THR beta agonist 55 atopic dermatitis neonatal 55 lomitapide 55 cardio renal 55 oxypurinol 55 PI3K/Akt pathway inhibitor 55 surgical adhesions 55 oncology infectious diseases 55 neurological disorders 55 antiviral therapeutics 55 familial amyloidotic polyneuropathy FAP 55 topically delivered 55 ddRNAi 55 retinal vein occlusion RVO 55 powder inhalers 55 topical formulation 55 PNP inhibitor 55 viral hemorrhagic fevers 55 glaucoma 55 rheumatoid arthritis psoriatic arthritis 55 treat chronic sinusitis 55 hypoparathyroidism 55 FOLOTYN ® 55 molecular biomarkers 55 anticancer treatments 55 immuno modulatory 55 CCR9 antagonist 55 LPM TM 55 chemotherapy induced neutropenia 55 TG# [003] 55 macular hole 55 neurologic disorders 55 Panzem R 55 inflammatory acne 55 Amphotericin B 55 Atrigel 55 XP #L 55 toenail onychomycosis 55 gastrointestinal GI motility disorders 55 diabetic neuropathic pain 55 VEGF inhibitors 55 chronic viral infections 55 inflammatory ocular 55 postsurgical pain 55 SNT MC# 55 diagnostic assays 55 OSI Eyetech 55 molecular imaging radiopharmaceutical 55 catheter occlusion 55 therapeutic monoclonal antibodies 55 therapies 55 candidiasis 55 non infectious uveitis 55 fibromyalgia syndrome 55 psoriasis Crohn disease 55 related macular degeneration 55 QUADRAMET R 55 Hsp# inhibition 55 postoperative ileus POI 55 proliferative retinopathy 55 rheumatoid arthritis gout 55 cataract glaucoma 55 intra abdominal infections 55 lupus nephritis 55 ocular itching associated 55 EnzymeRx 55 ospemifene 55 Mark HN Corrigan 55 complement inhibitor eculizumab 55 PEGylation 55 autologous cellular therapy 55 vaginally administered lidocaine 55 LentiVector technology 55 esophageal candidiasis 55 proprietary PEGylation 55 VEGF Trap 55 Light Infusion Therapy 55 opioid tolerant patients 55 post surgical adhesions 55 Shigamabs ® 55 Cellgate patented transporter 55 telomerase activators 55 neuroscience autoimmune 55 invasive candidiasis 55 quinolone antibiotic 55 Ophthotech 55 PharmFilm ® 55 anti CD# antibodies 55 congenital ichthyosis 55 Parkinson disease multiple sclerosis 55 Myolimus 55 systemic scleroderma 55 cardiovascular disorders 55 commercialize Aganocides 55 autologous cell 55 ELADUR ™ 55 cutaneous T 55 including eniluracil ADH 55 ostarine 55 diagnostic biomarkers 55 Onalta 55 antiangiogenesis therapies 55 IAP inhibitors 55 OTCBB INSV 55 neovascular age 55 investigational compounds 55 myelofibrosis 55 vascular occlusive diseases 55 engineered RAP peptides 55 rheumatoid arthritis psoriasis Crohn 55 Cerashield 55 minimally invasive treatments 55 nephropathic cystinosis 55 secretory diarrhea 55 degenerative retinal diseases 55 Photodynamic therapy PDT 55 excessive underarm sweating 55 Transdel TM 55 BXT # 55 AERx ® 55 hypervascular tumors 55 delta gamma agonist 55 BHT DNA 55 proprietary transdermal 55 ocular 55 atypical Hemolytic Uremic Syndrome 54 anterior uveitis 54 myeloproliferative diseases 54 Diabetic Macular Edema 54 ACV1 54 theranostic 54 Exelixis compounds 54 Prodarsan R 54 gastrointestinal GI disorders 54 Inc. Nasdaq NLTX 54 osteolytic bone disease 54 Aviptadil 54 biosurgical 54 Ozurdex 54 ophthalmic therapeutics 54 diabetic nephropathy 54 staphylococcal infections 54 Actinic Keratosis 54 Alessandro Riva 54 pemphigus vulgaris 54 ZFP Therapeutics 54 nonunion fractures 54 IBV Valve System 54 ALN TTR 54 Neovascular AMD 54 Intravitreal injections 54 KL4 surfactant 54 prescribed proton pump 54 Huntingtons disease 54 MMP inhibitors 54 radionuclide therapy 54 noninfectious uveitis 54 vascular disrupting agents 54 oral prodrug 54 CEQ# 54 multi kinase inhibitor 54 seborrheic dermatitis 54 oncolytic viruses 54 psoriasis IBD 54 candidates Azedra TM 54 metastatic liver 54 MTP inhibitor 54 Familial Adenomatous Polyposis FAP 54 chronic inflammatory 54 solid organ transplantation 54 Curaxin 54 dexanabinol 54 endocrine diseases 54 respiratory gastrointestinal 54 Sezary syndrome 54 immunocompetent patients 54 PhotoPoint R 54 PI3K inhibitors 54 post operative ileus 54 diseases chronic granulomatous 54 chronic neuropathic pain 54 tafamidis 54 CMV retinitis 54 Azedra TM Onalta TM 54 commercializes therapeutics 54 transdermal drug 54 interventional therapies 54 superficial bladder cancer 54 Bevasiranib 54 hematologic malignancies 54 immune modulators 54 COPD asthma 54 neuroendocrine tumors 54 JAK2 inhibitor 54 gastrointestinal diseases 54 external counterpulsation systems 54 antibody therapies 54 chronic thromboembolic pulmonary 54 protein kinase inhibitors 54 severe gastroparesis 54 immunological disorders 54 gynecologic procedures 54 muscarinic receptor agonist 54 systemic RNA interference 54 Leber congenital amaurosis LCA 54 aptamer therapeutics 54 symptomatic benign prostatic 54 diabetic retinopathy glaucoma 54 Hereditary angioedema HAE 54 Soliris TM eculizumab 54 gastro intestinal inflammation 54 Leber Hereditary Optic Neuropathy 54 histone deacetylase HDAC inhibitors 54 Raynaud syndrome 54 pulmonary hypertension PH 54 AzaSite Plus 54 Hepatocellular Carcinoma HCC 54 xerostomia 54 venomics 54 Nanobodies 54 mediated amyloidosis ATTR hypercholesterolemia 54 iSONEP 54 luliconazole 54 small molecule activators 54 nosocomial pneumonia 54 Tr DNA 54 actinic solar 54 systemic juvenile idiopathic 54 fluocinolone acetonide 54 Mitoxantrone 54 primary immunodeficiency PI 54 symptomatic neurogenic orthostatic hypotension 54 predominantly classic subfoveal 54 Stargardt Macular Dystrophy 54 RNA interference RNAi therapeutics 54 diabetic ulcers 54 neuropathic pain spasticity 54 lysosomal storage diseases 54 Visudyne R 54 Retisert ® 54 Combivir Kivexa 54 Homspera TM 54 Ketotransdel TM 54 ophthalmology 54 choroidal vasculopathy 54 Hsp# inhibitors 54 metastatic bone 54 proprietary Dicer Substrate Technology 54 NYSE Amex AEN 54 cancer cachexia 54 GED aPC 54 Acologix 54 TÎ ² 4 54 neuropathies 54 tranilast 54 aerosolized KL4 surfactant 54 postherpetic neuralgia PHN 54 polymerase inhibitors 54 postoperative ileus 54 product platforms AZX# 54 nitric oxide donating 54 proliferative disorders 54 sorafenib tablets 54 serologically active systemic lupus 54 dermatologic diseases 54 systemic lupus erythematosus lupus 54 unoprostone isopropyl 54 Peyronie Disease 54 hypereosinophilic syndrome 54 novel oral anticoagulant 54 Surfactant Replacement Therapies SRT 54 autoimmune diseases inflammatory 54 arthritis cardiovascular disease 54 herpes labialis 54 thrombotic disorders 54 plaque excision systems 54 vascular abnormalities 54 evaporative dry 54 relapsed leukemia 54 vaginal candidiasis 54 Phase IIb clinical trials 54 humanized monoclonal antibodies 54 Retinitis Pigmentosa RP 54 Medidur FA 54 Kleanthis G. Xanthopoulos Ph.D. 54 Onalta TM 54 biologic therapeutics 54 either acutely decompensated 54 anticoagulant reversing agent 54 neurogenic orthostatic hypotension 54 antagomirs 54 catalytic antioxidant compounds 54 pulmonary disorders 54 malignant infectious 54 metastatic neuroendocrine tumors 54 metabolic diseases 54 protein therapeutics 54 novel therapeutic antibodies 54 ulimorelin 54 osteoporosis osteoarthritis 54 inflammatory cardio metabolic 54 liver fibrosis 54 volociximab 54 Rhucin ® recombinant 54 nausea vomiting BEMA Granisetron 54 receptor inhibitors 54 iobenguane 54 opioid induced bowel dysfunction 54 Injury ALI 54 Factor VIIa 54 Neovascular 54 HepDirect prodrug 54 ALN HTT 54 Nanobody ® 54 ANCA associated 54 EVIZON TM squalamine lactate 54 immunoregulation 54 skeletal metastases 54 basal cell carcinoma BCC 54 infectious diseases autoimmune 54 molecular chaperone regulation 54 injury ischemic spastic 54 Affibody ® molecules 54 intraocular 54 choroidal neovascularisation 53 tetrasodium 53 iSONEP ™ 53 interstitial cystitis IC 53 enhanced skin permeation 53 thrombolytic agent 53 AZX# 53 targeted anticancer therapeutics 53 immunomodulators 53 Dicer Substrate Technology 53 gastrointestinal infectious 53 regenerative medicine therapies 53 sarcoma melanoma 53 Curaxins 53 NNR Therapeutics 53 kinase inhibitors 53 P#X# antagonist 53 nitric oxide donating prostaglandin 53 immune mediated 53 Retinopathy 53 Aganocide ® 53 Obstructive Pulmonary Disease 53 vascular diseases 53 MAXY G# 53 atrial arrhythmias 53 selective androgen receptor modulators 53 RSD# oral 53 Aptocine 53 vitreoretinal 53 Chrysalin 53 debilitating complication 53 essential thrombocythemia ET 53 Aganocide TM 53 diabetic microvascular complications 53 Puricase PEG uricase 53 Jerini Ophthalmic 53 resolvin 53 treating neuropathic pain 53 cryptococcosis 53 Xanafide 53 neurosurgery laparoscopic surgery 53 electrotherapeutic 53 asthma COPD Chronic 53 atherosclerosis hypertension 53 systemic lupus erythematosus psoriasis 53 opioid induced constipation OIC 53 interventional neuroradiology 53 inherited retinal degeneration 53 urologic disease 53 blood coagulation disorders 53 post herpetic 53 TMS Therapy 53 radiotherapeutic 53 opioid bowel dysfunction 53 Delivery System NTDDS 53 antibody therapeutics 53 renal anemia 53 TNF antagonist 53 diabetic gastroparesis 53 neural disorders 53 Nasdaq IMMU biopharmaceutical 53 topical anti infectives 53 oral PTH 53 autoimmune disorders 53 InSite Vision 53 tuberous sclerosis TS 53 preclinical compounds 53 incyclinide 53 Cobalamin TM mediated 53 cyclophilin inhibitor 53 atrial tachyarrhythmias 53 molecular imaging pharmaceuticals 53 Cobalamin 53 novel VDA molecule 53 Cutanea 53 therapeutic modality 53 Aganocide compounds 53 expanded autologous cellular 53 Logical Therapeutics 53 spinal pathologies 53 rheumatoid arthritis 53 CORT # 53 enzyme cofactor 53 disease Molluscum Contagiosum 53 Aganocide 53 hematological malignancy 53 Xerostomia 53 chronic degenerative diseases 53 topical diclofenac 53 chronic periodontitis 53 forodesine 53 Actemra tocilizumab 53 LEP ETU 53 Diabetic Retinopathy 53 pemphigus 53 BCR ABL inhibitors 53 humanized antibodies 53 Medidur 53 Bioral ® 53 omecamtiv mecarbil 53 vitamin D analogs 53 herpes virus infections 53 Zemiva ™ 53 patented Bioral 53 nicotinic alpha 7 53 embolotherapy 53 cardiovascular metabolic diseases 53 Cleviprex TM clevidipine 53 acute GvHD 53 HGS ETR1 mapatumumab 53 Li Fraumeni Syndrome 53 RNA antagonists 53 PsychoGenics 53 topical ophthalmic 53 LHON 53 eczema psoriasis 53 antigen sparing 53 ocular allergy 53 diabetic retinopathy macular degeneration 53 urologic disorders 53 Zenvia ™ 53 terlipressin 53 HQK 53 photodynamic treatment 53 castrate resistant prostate cancer 53 painful diabetic neuropathy 53 heterozygous FH 53 unmet medical 53 anti fibrotic 53 PGL# 53 Prodarsan ® 53 gastrointestinal malignancies 53 hESC derived RPE cells 53 radiofrequency ablation RFA 53 Hurler syndrome 53 haematological malignancies 53 Archemix Corp. 53 Lauriad 53 pulmonary arterial hypertension PAH 53 LNP formulations 53 GPCR targets 53 Nerve Targeting Drug 53 AMPK activators 53 Inflazyme 53 paroxysmal nocturnal hemoglobinuria 53 carbohydrate polymers 53 renal kidney 53 Sjogren syndrome 53 rheumatic diseases 53 efficacious treatments 53 small molecule agonists 53 therapeutic antibodies 53 histone deacetylase HDAC inhibitor 53 anticancer agents 53 commercializing interventional 53 iGVHD 53 Therapeutix 53 Polyphenon ® E 53 colorectal cancer liver metastases 53 Gorlin syndrome 53 Immunotherapeutic 53 pharmacological approaches 53 POSIDUR TM ELADUR TM 53 TRAIL receptor antibodies 53 vitreous hemorrhage 53 bromfenac 53 primary hyperparathyroidism 53 diabetic neuropathy 53 Retisert TM 53 SinuNase ™ 53 GelSite polymer 53 JAK2 inhibitors 53 KL4 Surfactant 53 neovascular AMD 53 commercialize AzaSite 53 diseases fat malabsorption 53 commercialize conjugates consisting 53 somatostatin analogue 53 gastro intestinal disorders 53 Surgical resection 53 DIQUAS 53 Revimmune TM 53 Serostim ® 53 thrombolytic agents 53 Neuraltus 53 nonmelanoma skin cancers 53 Inflammatory diseases 53 Quark Biotech Inc. 53 Aggrastat ® tirofiban hydrochloride 53 injectable depot 53 Dr. Sosne 53 Parkinson disease epilepsy 53 immune modulator 53 Trofex 53 anticancer therapeutics 53 hypoxia activated prodrug 53 verteporfin 53 Bioral 53 myasthenia gravis Huntington 53 microplasmin 53 DermaPrep 53 GGF2 53 neuro vascular 53 lintuzumab SGN 53 Wet macular degeneration 53 resorbable biomaterials 53 vidofludimus 53 gastrointestinal cancers 53 RNAi therapeutic targeting PCSK9 53 anticancer therapy 53 Anti VEGF 53 proteins peptides 53 Diabetic neuropathy 53 GLASSIA 53 anti angiogenic therapy 53 STELARA ™ 53 dermal wounds 53 non nucleoside HCV 53 venous leg 53 KineMed 53 rxRNA ™ compounds 53 Solazed ™ 53 Trofex TM 53 enhanced pharmacologic 53 commercializes biotherapeutics 53 macular disease 53 solid tumors 53 prophylactic therapy 53 anti amnesic 53 pharmacogenomic tests 53 Personalized Immunotherapy 53 Therapies SRT 53 dirucotide MBP# 53 treat dysmenorrhea 53 Onychomycosis 53 biodegradable implant 53 PDE# inhibitors 53 photocoagulation 53 recombinant therapies 53 fibrosis oncology 53 immunosuppressive therapies 53 multiple sclerosis rheumatoid arthritis 53 rheumatoid arthritis lupus 53 Vitrasert ® 53 ibudilast 53 Generx TM 53 immunomodulatory therapy 53 multiple sclerosis psoriasis 53 bepotastine 53 cystic fibrosis chronic pancreatitis 53 ThermoDox R 53 CTAP# Capsules 53 lupus scleroderma 53 EP #R 53 delta isoform 53 PDE7 53 generation purine nucleoside 53 Hepatitis B Hepatitis C 53 vascular insufficiency 53 Tomophase 53 Proquin XR 53 Mohs micrographic surgery 53 dihydrochloride Tablets 53 delayed CINV 52 cardiometabolic diseases 52 pain syndromes 52 transplantation HCT 52 Tectin TM 52 transthyretin TTR mediated amyloidosis 52 Major Depressive Disorder MDD 52 QLT# 52 homozygous familial hypercholesterolemia 52 immune modulatory 52 fusion enhancers 52 novel peptide therapeutics 52 epithelial tumors 52 cystic fibrosis allergic rhinitis 52 oral salmon calcitonin 52 rusalatide acetate 52 modified glutathione analog 52 therapeutic monoclonal antibody 52 biased ligand 52 coronary carotid 52 INxin 52 severe hypersensitivity reactions 52 dermatology therapies 52 myopic CNV 52 idiopathic pulmonary fibrosis IPF 52 allergic conjunctivitis 52 endocrine disorders 52 AA Amyloidosis 52 glioblastoma multiforme GBM 52 Nasdaq IDIX biopharmaceutical 52 IMiDs 52 secondary hyperparathyroidism